AKTS (Aktis Oncology) Construction In Progress: $3.07 Mil (As of Mar. 2026)


AKTS Aktis Oncology Inc AKTS
9 GF Score
Price $29.37
! 3 Warning Signs
View Full Analysis

What is Aktis Oncology Construction In Progress?

Aktis Oncology AKTS -5.49% 9 Construction In Progress is $3.07 Mil as of Mar. 2026. GuruFocus rates AKTS with a GF Score™ of 9/100. The stock has 3 warning signs investors should review.

Aktis Oncology's quarterly construction in progress increased from Sep. 2025 ($3.96 Mil) to Dec. 2025 ($7.01 Mil) but then declined from Dec. 2025 ($7.01 Mil) to Mar. 2026 ($3.07 Mil).

Aktis Oncology's annual construction in progress increased from Dec. 2023 ($0.40 Mil) to Dec. 2024 ($1.33 Mil) and increased from Dec. 2024 ($1.33 Mil) to Dec. 2025 ($7.01 Mil).

Aktis Oncology Construction In Progress Historical Data

* Premium members only.

The historical data trend for Aktis Oncology's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aktis Oncology Construction In Progress Chart

Aktis Oncology Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Construction In Progress
0.56 0.40 1.33 7.01

Aktis Oncology Quarterly Data
Dec22 Dec23 Sep24 Dec24 Mar25 Sep25 Dec25 Mar26
Construction In Progress Get a 7-Day Free Trial 1.33 0.00 3.96 7.01 3.07
AKTS
9GF Score
Aktis Oncology Inc AKTS
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aktis Oncology Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of $3.07 Mil mean?
Aktis Oncology (AKTS) has a Construction In Progress of $3.07 Mil as of Mar. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on Aktis Oncology and its competitors.
Is Aktis Oncology's Construction In Progress too high?
Aktis Oncology's current Construction In Progress is $3.07 Mil. Overall, Aktis Oncology has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does Aktis Oncology's Construction In Progress compare to OLMA and EYPT?
Aktis Oncology's Construction In Progress of $3.07 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Biotechnology company?
A good Construction In Progress depends on the Biotechnology industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Aktis Oncology and its competitors. Aktis Oncology's current Construction In Progress is $3.07 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aktis Oncology stock overvalued right now?
Aktis Oncology (AKTS) has a current Construction In Progress of $3.07 Mil. The current Construction In Progress is $3.07 Mil. Aktis Oncology's overall GF Score™ is 9/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Aktis Oncology (AKTS), the current Construction In Progress is $3.07 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aktis Oncology Business Description

Address 17 Drydock Avenue, Suite 17-401, Boston, MA, USA, 02210
Aktis Oncology Inc is a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations, including those not addressed by existing platform technologies. The company specializes in developing targeted alpha radiopharmaceuticals for solid tumors such as breast, lung, colorectal, bladder, and liver cancers. Its pipeline products include AKY-1189 and AKY-2519, focusing on solid tumors. The company has one operating and reportable segment focused on the research and development of targeted radiopharmaceuticals to treat a broad range of solid tumor cancers. The company generates revenue from Collaboration agreement.
9GF Score

Get the complete analysis for AKTS

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$29.37
Price